S. Dewiputri and M. Sidik, “Clinical Outcome of Intravenous Glucocorticoid and Rituximab in Moderate to Severe Thyroid Eye Disease”, OI, vol. 42, no. 2, Feb. 2017, doi: 10.35749/journal.v42i2.82.